EU Startups — Swiss medtech Aktiia raises €5.6 million to bring its hypertension monitor bracelet to market

“Aktiia’s bracelet and algorithms have now been validated in clinical trials against arterial lines (the gold standard for clinical reference) and in ambulatory settings. Never before has it been possible to measure blood pressure profiles, at any time, over long periods. This valuable and unique dataset will allow for broader insights into the diagnosis and treatment of hypertension, the largest epidemic of humankind.”